Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04445909 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Validation of Continuous Transcutaneous Carbon Dioxide Monitoring in VA-ECMO Patients

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Jan 31, 2025 → Dec 31, 2026
See other at-risk trials from Medical University of Vienna

Record History

  1. Primary completion pushed from Jan 31, 2025 to Dec 31, 2026 Completion pushed from Dec 31, 2025 to Dec 31, 2026 · Eligibility criteria expanded, about 2 words Show 2 more changesShow less
    • Completion pushed from Dec 31, 2025 to Dec 31, 2026
    • Eligibility criteria expanded, about 2 words
  2. Primary completion date: Jul 31, 2023 to Jan 31, 2025 Completion date: Jul 31, 2023 to Dec 31, 2025v4 Show 1 more changeShow less
    • Completion date: Jul 31, 2023 to Dec 31, 2025
  3. Primary and study completion dates: Jul 31, 2022 to Jul 31, 2023v3
  4. Primary and study completion dates: Dec 31, 2021 to Jul 31, 2022v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Carbon dioxide in patients on veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is eliminated via respirator as well as via the oxygenator's membrane of the ECMO machine. Consequently, monitoring of end-tidal carbon dioxide tensions is limited, which can result in marked swings towards non-physiological values. Hyper- and hypocapnia, however, can have detrimental effects on organ perfusion in a great number of patients supported with VA-ECMO. Continuous, rapidly applicable monitoring of reliable carbon dioxide measures would therefore be extremely helpful to prevent harmful deviations from the norm. The investigators therefore try to assess the accuracy and the precision of continuously measured non-invasive transcutaneous carbon dioxide partial pressures when compared with tensions determined by blood gas analysis.
Trial Details
NCT Number NCT04445909
Lead Sponsor Medical University of Vienna
Conditions Carbon Dioxide
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov